Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02205346 · ClinicalTrials.gov registry record
Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea
A clinical trial, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- 130
- Enrollment target
NCT02205346: Completed study, sponsored by Eastern Virginia Medical School.
NCT02205346 is a clinical trial that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02205346 has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
Investigate urinary leukotriene E4 levels and determine if there is a correlation with severity of obstructive sleep apnea. The investigators then would like to determine a threshold level which could then be used for confirmation of diagnosis of obstructive sleep apnea (OSA).
Primary Outcome
assess urinary leukotriene E4 levels in children with obstructive sleep apnea (OSA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-12 |
What the finished NCT02205346 record still lists
NCT02205346 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02205346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02205346 about?
NCT02205346 is a clinical study titled "Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea". Investigate urinary leukotriene E4 levels and determine if there is a correlation with severity of obstructive sleep apnea. The investigators then would like to determine a threshold level which could then be used for confirmation of diagnosis of obstructive sleep apnea (OSA).
What is the current status of trial NCT02205346?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2014-02. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02205346?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia